1. Home
  2. MDXG vs NG Comparison

MDXG vs NG Comparison

Compare MDXG & NG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDXG
  • NG
  • Stock Information
  • Founded
  • MDXG 2006
  • NG 1984
  • Country
  • MDXG United States
  • NG Canada
  • Employees
  • MDXG N/A
  • NG N/A
  • Industry
  • MDXG Biotechnology: Pharmaceutical Preparations
  • NG Precious Metals
  • Sector
  • MDXG Health Care
  • NG Basic Materials
  • Exchange
  • MDXG Nasdaq
  • NG Nasdaq
  • Market Cap
  • MDXG 877.4M
  • NG 1.5B
  • IPO Year
  • MDXG N/A
  • NG N/A
  • Fundamental
  • Price
  • MDXG $6.67
  • NG $4.83
  • Analyst Decision
  • MDXG Strong Buy
  • NG Buy
  • Analyst Count
  • MDXG 2
  • NG 1
  • Target Price
  • MDXG $12.50
  • NG $7.00
  • AVG Volume (30 Days)
  • MDXG 771.8K
  • NG 4.0M
  • Earning Date
  • MDXG 07-30-2025
  • NG 06-25-2025
  • Dividend Yield
  • MDXG N/A
  • NG N/A
  • EPS Growth
  • MDXG N/A
  • NG N/A
  • EPS
  • MDXG 0.27
  • NG N/A
  • Revenue
  • MDXG $352,375,000.00
  • NG N/A
  • Revenue This Year
  • MDXG $9.55
  • NG N/A
  • Revenue Next Year
  • MDXG $11.43
  • NG N/A
  • P/E Ratio
  • MDXG $25.11
  • NG N/A
  • Revenue Growth
  • MDXG 5.34
  • NG N/A
  • 52 Week Low
  • MDXG $5.47
  • NG $2.26
  • 52 Week High
  • MDXG $10.14
  • NG $5.06
  • Technical
  • Relative Strength Index (RSI)
  • MDXG 57.60
  • NG 66.53
  • Support Level
  • MDXG $5.86
  • NG $4.34
  • Resistance Level
  • MDXG $7.05
  • NG $4.71
  • Average True Range (ATR)
  • MDXG 0.24
  • NG 0.23
  • MACD
  • MDXG 0.11
  • NG 0.05
  • Stochastic Oscillator
  • MDXG 69.20
  • NG 99.70

About MDXG MiMedx Group Inc

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

About NG Novagold Resources Inc.

Novagold Resources Inc operates in the gold mining industry, focused on advancing the Donlin Gold project in Alaska. The Donlin Gold project is held by Donlin Gold LLC (Donlin Gold), a limited liability company owned equally by wholly owned subsidiaries of NOVAGOLD and Barrick Gold Corporation (Barrick). The company includes exploration and development activities of gold and other presious metals.

Share on Social Networks: